Agilent Technologies, Inc. - Diagnostics and Genomics SS CD GlasgowCancerPlus, 96
The Agilent SureSelect Cancer All-In-One Glasgow Cancer Plus kit (part number 5191-6951) is designed for comprehensive genomic profiling of cancer samples. This kit enables the simultaneous detection of multiple types of genomic alterations, including single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and gene fusions, across a broad panel of cancer-related genes. Optimized for high-throughput workflows, the kit supports up to 96 reactions and is compatible with next-generation sequencing (NGS) platforms. It provides robust performance with formalin-fixed, paraffin-embedded (FFPE) and fresh frozen samples, facilitating accurate and sensitive variant detection for cancer research applications.